Subtopic Deep Dive
Centella asiatica Neuroprotection
Research Guide
What is Centella asiatica Neuroprotection?
Centella asiatica neuroprotection examines the brain-protective effects of Centella asiatica extracts and compounds like asiatic acid against oxidative stress, neurodegeneration, and Alzheimer's models.
Studies demonstrate Centella asiatica's antioxidant properties and cognitive enhancement in streptozotocin-induced Alzheimer's rat models (Veerendra Kumar and Gupta, 2003, 244 citations). Research highlights anti-cholinesterase activity and triterpenoid mechanisms bridging traditional Ayurvedic use to modern neuroprotective applications (Orhan, 2012, 220 citations). Over 10 key papers from 2003-2022, with 200+ citations each, focus on pathways like PI3K/AKT (Long et al., 2021, 443 citations).
Why It Matters
Centella asiatica extracts reduce oxidative stress and improve cognition in Alzheimer's rat models, offering potential therapeutics for neurodegeneration (Veerendra Kumar and Gupta, 2003). Triterpenoids like asiatic acid target PI3K/AKT pathways, linking traditional medicine to AD/PD prevention (Long et al., 2021). Antioxidant and AChE inhibitory activities support drug development from plant bioactives, as shown in screening studies (Mathew and Subramanian, 2014; Mukherjee et al., 2007). These findings bridge herbal remedies to clinical pharmacology for aging populations.
Key Research Challenges
Bioavailability Across BBB
Centella asiatica compounds face blood-brain barrier penetration issues, limiting neuroprotective efficacy in vivo (Bhattacharya et al., 2022). Phyto-nanotechnology approaches aim to enhance delivery but require optimization (Bhattacharya et al., 2022). Clinical translation remains limited by poor absorption data.
Standardized Extract Variability
Differences in phenolic and flavonoid content across Centella asiatica extracts affect antioxidant reproducibility (Pittella et al., 2009). Screening studies show variable AChE inhibition due to extraction methods (Mukherjee et al., 2007). Standardization protocols are needed for reliable neuroprotection assays.
Mechanism Specificity in Models
Neuroprotective effects in streptozotocin Alzheimer's models need validation across PD and other disorders (Veerendra Kumar and Gupta, 2003). PI3K/AKT targeting overlaps with general natural products, lacking Centella-specific pathway elucidation (Long et al., 2021). Human trial data is scarce.
Essential Papers
PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
Hui‐Zhi Long, Yan Cheng, Ziwei Zhou et al. · 2021 · Frontiers in Pharmacology · 443 citations
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two typical neurodegenerative diseases that increased with aging. With the emergence of aging population, the health problem and economic b...
Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery
Ghulam Hussain, Jing Wang, Azhar Rasul et al. · 2019 · International Journal of Biological Sciences · 287 citations
Peripheral nerve injury is a complex condition with a variety of signs and symptoms such as numbness, tingling, jabbing, throbbing, burning or sharp pain. Peripheral nerves are fragile in nature an...
Effect of <i>Centella asiatica</i> on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats
MH Veerendra Kumar, YK Gupta · 2003 · Clinical and Experimental Pharmacology and Physiology · 244 citations
Summary 1. Centella asiatica , an Indian medicinal plant, has been described as possessing central nervous system activity, such as improving intelligence. In addition, we have demonstrated that C....
Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Muneeb U. Rehman, Adil Farooq Wali, Anas Ahmad et al. · 2018 · Current Neuropharmacology · 244 citations
Nature has bestowed mankind with surplus resources (natural products) on land and water. Natural products have a significant role in the prevention of disease and boosting of health in humans and a...
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
Mehdi Sharifi‐Rad, Chintha Lankatillake, Daniel A. Dias et al. · 2020 · Journal of Clinical Medicine · 240 citations
Among the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs f...
Antioxidant and Cytotoxic Activities of Centella asiatica (L) Urb.
Frederico Pittella, Rafael C. Dutra, Dalton Dittz et al. · 2009 · International Journal of Molecular Sciences · 240 citations
In the present study, the phenolic (Folin-Dennis) and flavonoid (colorimetric assay) constituents, antioxidant [2,2-diphenyl-2-picrylhydrazyl hydrate (DPPH) assay] and cytotoxic activities of an aq...
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Tanima Bhattacharya, Giselle A. Borges e Soares, Hitesh Chopra et al. · 2022 · Materials · 235 citations
The strategies involved in the development of therapeutics for neurodegenerative disorders are very complex and challenging due to the existence of the blood-brain barrier (BBB), a closely spaced n...
Reading Guide
Foundational Papers
Start with Veerendra Kumar and Gupta (2003, 244 citations) for Alzheimer's rat model evidence; Pittella et al. (2009, 240 citations) for antioxidant assays; Orhan (2012, 220 citations) for traditional-to-modern overview.
Recent Advances
Long et al. (2021, 443 citations) on PI3K/AKT pathways; Bhattacharya et al. (2022, 235 citations) on nanotech delivery; Sharifi-Rad et al. (2020, 240 citations) on NDD pharmacotherapeutics.
Core Methods
Core techniques: intracerebroventricular streptozotocin models, DPPH/FRAP antioxidant assays, AChE inhibition screening, PI3K/AKT pathway analysis (Veerendra Kumar and Gupta, 2003; Pittella et al., 2009; Mathew and Subramanian, 2014).
How PapersFlow Helps You Research Centella asiatica Neuroprotection
Discover & Search
Research Agent uses searchPapers and exaSearch to find Centella asiatica studies like 'Effect of Centella asiatica on cognition...'(Veerendra Kumar and Gupta, 2003), then citationGraph reveals 244 citing papers on Alzheimer's models. findSimilarPapers expands to triterpenoid mechanisms from Orhan (2012).
Analyze & Verify
Analysis Agent applies readPaperContent to extract antioxidant data from Pittella et al. (2009), verifies claims with CoVe chain-of-verification, and runs PythonAnalysis on DPPH assay metrics using pandas for statistical comparison. GRADE grading scores evidence strength for AChE inhibition (Mathew and Subramanian, 2014).
Synthesize & Write
Synthesis Agent detects gaps in BBB delivery from Bhattacharya et al. (2022), flags contradictions in extract variability (Pittella et al., 2009), and generates exportMermaid diagrams of PI3K/AKT pathways. Writing Agent uses latexEditText, latexSyncCitations for Kumar/Gupta (2003), and latexCompile for publication-ready reviews.
Use Cases
"Extract and plot antioxidant activity data from Centella asiatica papers."
Research Agent → searchPapers('Centella asiatica DPPH') → Analysis Agent → readPaperContent(Pittella 2009) → runPythonAnalysis(pandas plot flavonoids vs DPPH) → matplotlib graph of IC50 values.
"Compile LaTeX review on Centella asiatica Alzheimer's neuroprotection."
Synthesis Agent → gap detection(Veerendra Kumar 2003 + Long 2021) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF with neuroprotective pathway figure).
"Find code for modeling Centella asiatica AChE inhibition."
Research Agent → searchPapers('Centella asiatica AChE simulation') → paperExtractUrls(Mathew 2014) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(docking script validation).
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ Centella papers) → citationGraph → DeepScan(7-step verification on oxidative stress claims from Kumar/Gupta 2003). Theorizer generates hypotheses on triterpenoid-PI3K/AKT links from Long et al. (2021) via contradiction flagging and pathway synthesis.
Frequently Asked Questions
What defines Centella asiatica neuroprotection?
Centella asiatica neuroprotection involves extracts and asiatic acid protecting neurons from oxidative stress and Alzheimer's pathology via antioxidant and cognitive-enhancing mechanisms (Veerendra Kumar and Gupta, 2003; Orhan, 2012).
What methods assess its neuroprotective effects?
Methods include streptozotocin rat Alzheimer's models for cognition/oxidative stress, DPPH assays for antioxidants, and AChE inhibition screening (Veerendra Kumar and Gupta, 2003; Pittella et al., 2009; Mathew and Subramanian, 2014).
What are key papers on this topic?
Top papers: Veerendra Kumar and Gupta (2003, 244 citations) on Alzheimer's models; Pittella et al. (2009, 240 citations) on antioxidants; Orhan (2012, 220 citations) on neuroprotective potential.
What open problems exist?
Challenges include BBB bioavailability, extract standardization, and clinical trials beyond rodent models (Bhattacharya et al., 2022; Pittella et al., 2009).
Research Medicinal Plants and Neuroprotection with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Centella asiatica Neuroprotection with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers